Biologic Therapy & Long-Term Medication

Review medication access, monitoring and continuity of care for immune-mediated or inflammatory disease.

Key points

  • Uncertain access or ongoing self-pay costs for a prescribed biologic.
  • International hospitals with relevant rheumatology, dermatology or immunology services.
  • Share the condition, current regimen, country and possible travel window. Your prescribing doctor should review any proposed medication changes.

Immune-mediated and inflammatory disease

Ask the specialist about local prescribing, access to the exact product and the monitoring schedule.

Allergy, immunotherapy and severe asthma review

Gather allergy tests, treatment history and recent respiratory evaluations.

Read the guide

Dermatology review for chronic skin conditions

Include current treatments, response and any previously documented adverse effects.

Read the guide

Rheumatology and biologic access

Prepare records of previous therapies and why they were changed.

Read the guide

Biologics in cancer care

Review drug availability and monitoring in the context of the complete oncology plan.

Targeted therapy and immunotherapy review

Ask an oncology team to review the pathology, prior regimens and biomarker results together.

Read the guide

Continue exploring

Oncology

Arrange a second opinion, multidisciplinary review or an assessment of surgical, radiation and drug-treatment pathways.

Explore pathway

General & Specialist Care

Plan routine visits, specialist consultations, procedures and follow-up for chronic conditions.

Explore pathway

Diagnostic Imaging

Coordinate imaging and diagnostic workups when waiting for scans or a second review would hold up your next decision.

Explore pathway

Free Pathway Scan

See whether a China pathway fits.

Share the condition, current regimen, country and possible travel window. Your prescribing doctor should review any proposed medication changes.